Welcome to our dedicated page for Corteva news (Ticker: $CTVA), a resource for investors and traders seeking the latest updates and insights on Corteva stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Corteva's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Corteva's position in the market.
Corteva, Inc. (NYSE: CTVA) executives will speak at the 2024 BMO Farm to Market Chemicals Conference on May 15, 2024. The webcast will be available for registration on the Corteva Investor Relations website, with a replay available until August 15, 2024.
Corteva reported first-quarter 2024 results in line with expectations, showcasing strength in the Seed business but decline in Crop Protection. The company reaffirmed its 2024 guidance, supported by controllable factors.
First-quarter net sales decreased 8%, with Seed net sales growing 2% and Crop Protection net sales decreasing 20%. GAAP income and EPS were $376 million and $0.53 per share, respectively. Operating EBITDA was $1.03 billion, and Operating EPS was $0.89 per share.
The company reiterated its full-year 2024 guidance with expected net sales between $17.4 billion to $17.7 billion, Operating EBITDA between $3.5 billion to $3.7 billion, and Operating EPS between $2.70 to $2.90 per share.
